These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 15819668)
1. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Busch MP; Tobler LH; Saldanha J; Caglioti S; Shyamala V; Linnen JM; Gallarda J; Phelps B; Smith RI; Drebot M; Kleinman SH Transfusion; 2005 Apr; 45(4):492-9. PubMed ID: 15819668 [TBL] [Abstract][Full Text] [Related]
2. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience. Kleinman S; Glynn SA; Busch M; Todd D; Powell L; Pietrelli L; Nemo G; Schreiber G; Bianco C; Katz L; Transfusion; 2005 Apr; 45(4):469-79. PubMed ID: 15819665 [TBL] [Abstract][Full Text] [Related]
3. Reacting to an emerging safety threat: West Nile virus in North America. Stramer SL Dev Biol (Basel); 2007; 127():43-58. PubMed ID: 17486880 [TBL] [Abstract][Full Text] [Related]
4. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH; Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038 [TBL] [Abstract][Full Text] [Related]
5. Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic. Tobler LH; Bianco C; Glynn SA; Schreiber GB; Dille BJ; Prince HE; Lanciotti RS; Linnen JM; Gallarda J; Shyamala V; Smith D; Kleinman SH; Busch MP; Transfusion; 2005 Apr; 45(4):480-6. PubMed ID: 15819666 [TBL] [Abstract][Full Text] [Related]
6. Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening. Lai L; Lee TH; Tobler L; Wen L; Shi P; Alexander J; Ewing H; Busch M Transfusion; 2012 Feb; 52(2):447-54. PubMed ID: 21827506 [TBL] [Abstract][Full Text] [Related]
7. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Custer B; Tomasulo PA; Murphy EL; Caglioti S; Harpool D; McEvoy P; Busch MP Transfusion; 2004 Nov; 44(11):1547-54. PubMed ID: 15504158 [TBL] [Abstract][Full Text] [Related]
8. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. Busch MP; Caglioti S; Robertson EF; McAuley JD; Tobler LH; Kamel H; Linnen JM; Shyamala V; Tomasulo P; Kleinman SH N Engl J Med; 2005 Aug; 353(5):460-7. PubMed ID: 16079369 [TBL] [Abstract][Full Text] [Related]
10. West Nile virus in Canadian blood donors. Cameron C; Reeves J; Antonishyn N; Tilley P; Alport T; Eurich B; Towns D; Lane D; Saldanha J Transfusion; 2005 Apr; 45(4):487-91. PubMed ID: 15819667 [TBL] [Abstract][Full Text] [Related]
11. A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus. Biggerstaff BJ; Petersen LR Transfusion; 2009 Jun; 49(6):1151-9. PubMed ID: 19309472 [TBL] [Abstract][Full Text] [Related]
12. West Nile virus adheres to human red blood cells in whole blood. Rios M; Daniel S; Chancey C; Hewlett IK; Stramer SL Clin Infect Dis; 2007 Jul; 45(2):181-6. PubMed ID: 17578776 [TBL] [Abstract][Full Text] [Related]
13. Detection of West Nile virus in blood donations--United States, 2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2003 Aug; 52(32):769-72. PubMed ID: 12917583 [TBL] [Abstract][Full Text] [Related]
14. West Nile virus transmission through blood transfusion--South Dakota, 2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(4):76-9. PubMed ID: 17268405 [TBL] [Abstract][Full Text] [Related]
15. Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay. Pai A; Kleinman S; Malhotra K; Lee-Haynes L; Pietrelli L; Saldanha J Transfusion; 2008 Oct; 48(10):2184-9. PubMed ID: 18694466 [TBL] [Abstract][Full Text] [Related]
16. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [TBL] [Abstract][Full Text] [Related]
17. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing. Kleinman SH; Williams JD; Robertson G; Caglioti S; Williams RC; Spizman R; Morgan L; Tomasulo P; Busch MP Transfusion; 2009 Jun; 49(6):1160-70. PubMed ID: 19320866 [TBL] [Abstract][Full Text] [Related]
18. Feasibility of routine individual donation testing for West Nile virus RNA during epidemic season using the investigational Roche cobas TaqScreen West Nile virus test and cobas s 201 system prototype. Galel SA; Webster J; Roa L Transfusion; 2008 Jul; 48(7):1486-94. PubMed ID: 18466179 [TBL] [Abstract][Full Text] [Related]
19. Transfusion-associated transmission of West Nile virus--Arizona, 2004. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(36):842-4. PubMed ID: 15371966 [TBL] [Abstract][Full Text] [Related]
20. First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Delwart EL; Kalmin ND; Jones TS; Ladd DJ; Foley B; Tobler LH; Tsui RC; Busch MP Vox Sang; 2004 Apr; 86(3):171-7. PubMed ID: 15078251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]